Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1β/CXCL1 signalling pathway.
- Resource Type
- Article
- Source
- Cell Death Discovery; 4/10/2023, Vol. 9 Issue 1, p1-10, 10p
- Subject
- Language
- ISSN
- 20587716